Virtual Screening of DrugBank Reveals Two Drugs as New BCRP Inhibitors

Subtle Structural Differences Trigger Inhibitory Activity of Propafenone Analogues at the Two Polyspecific ABC Transporters: P-Glycoprotein (P-gp) and Breast Cancer Resistance Protein (BCRP)

(2016) Theresa Schwarz et al.   ChemMedChem

BCRP Inhibition: from Data Collection to Ligand-Based Modeling

(2014) Floriane Montanari et al.   Molecular Informatics

Computational classification models for predicting the interaction of drugs with P-glycoprotein and breast cancer resistance protein

(2014) S. Erić et al.   SAR AND QSAR IN ENVIRONMENTAL RESEARCH

Identification of Novel Breast Cancer Resistance Protein (BCRP) Inhibitors by Virtual Screening

(2013) Yongmei Pan et al.   MOLECULAR PHARMACEUTICS

The ChEMBL bioactivity database: an update

(2013) A. Patrícia Bento et al.   NUCLEIC ACIDS RESEARCH

The NumPy Array: A Structure for Efficient Numerical Computation

(2011) Stéfan van der Walt et al.   COMPUTING IN SCIENCE & ENGINEERING

PubChem's BioAssay Database

(2011) Y. Wang et al.   NUCLEIC ACIDS RESEARCH

ABCG2/BCRP Dysfunction as a Major Cause of Gout

(2011) Hirotaka Matsuo et al.   NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS

Mitoxantrone is expelled by the ABCG2 multidrug transporter directly from the plasma membrane

(2010) László Homolya et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES

Effects of rifampicin on the pharmacokinetics of roflumilast and roflumilast N-oxide in healthy subjects

(2009) Nassr Nassr et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY